pre-eclampsia

Embryo organoids created from stem cells are allowing scientists to model early pregnancy in laboratory settings, aiming to develop treatments for infertility, miscarriage, and pre-eclampsia.

Pre-eclampsia is a serious condition that causes more than 70,000 maternal deaths every year worldwide, and a potential new treatment has been discovered. This condition affects pregnant women and can lead to severe complications. The new treatment may help reduce the number of maternal deaths.

Pre-eclampsia is a serious health issue causing over 70,000 maternal deaths annually worldwide, and a potential new treatment has been discovered. This condition affects pregnant women and can lead to severe complications. The new treatment may significantly reduce mortality rates.

A potential treatment for pre-eclampsia is being developed, with blood filtering showing promising results in early trials. The method has performed well, offering hope for managing this pregnancy complication.

A study published in Nature on April 8, 2026, presents a single-cell multiomic atlas of the human maternal–fetal interface during pregnancy, revealing cell types, spatial niches, and transcriptional programs. The research identifies specific cell types linked to pre-eclampsia, spontaneous preterm birth, and miscarriage, offering insights into pregnancy-related complications.